Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Glutamate NMDA receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | 0.0851 | 0.9753 | 1 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0057 | 0.0295 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0057 | 0.0295 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0794 | 0.9078 | 0.905 |
Mycobacterium ulcerans | lipoprotein aminopeptidase LpqL | 0.0077 | 0.0542 | 1 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0057 | 0.0295 | 0.5 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0057 | 0.0295 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0057 | 0.0295 | 0.5 |
Schistosoma mansoni | NAALADASE L peptidase (M28 family) | 0.0558 | 0.626 | 1 |
Echinococcus multilocularis | glutaminyl peptide cyclotransferase | 0.0057 | 0.0295 | 0.0302 |
Leishmania major | glutaminyl cyclase, putative | 0.0057 | 0.0295 | 0.5 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0057 | 0.0295 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0057 | 0.0295 | 0.5 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0057 | 0.0295 | 0.5 |
Onchocerca volvulus | Glutaminyl cyclase homolog | 0.0057 | 0.0295 | 0.5 |
Trypanosoma brucei | glutaminyl cyclase, putative | 0.0057 | 0.0295 | 0.5 |
Brugia malayi | leucyl aminopeptidase | 0.0057 | 0.0295 | 0.5 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0057 | 0.0295 | 0.5 |
Brugia malayi | FXNA | 0.0057 | 0.0295 | 0.5 |
Trichomonas vaginalis | Clan MH, family M28, aminopeptidase S-like metallopeptidase | 0.0057 | 0.0295 | 0.5 |
Toxoplasma gondii | peptidase, M28 family protein | 0.0057 | 0.0295 | 0.5 |
Echinococcus granulosus | glutaminyl peptide cyclotransferase | 0.0057 | 0.0295 | 1 |
Echinococcus multilocularis | endoplasmic reticulum metallopeptidase 1 | 0.0057 | 0.0295 | 0.0302 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0057 | 0.0295 | 1 |
Echinococcus multilocularis | endoplasmic reticulum metallopeptidase 1 | 0.0057 | 0.0295 | 0.0302 |
Leishmania major | hypothetical protein, conserved | 0.0057 | 0.0295 | 0.5 |
Onchocerca volvulus | 0.0057 | 0.0295 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0578 | 0.6507 | 0.6401 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0057 | 0.0295 | 0.5 |
Mycobacterium tuberculosis | Probable lipoprotein aminopeptidase LpqL | 0.0077 | 0.0542 | 1 |
Brugia malayi | Peptidase family M28 containing protein | 0.0057 | 0.0295 | 0.5 |
Brugia malayi | nicalin | 0.0057 | 0.0295 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 3 | Anticonvulsant activity of compound was measured by the Number of rats protected / Number of rats tested at 5 mg/kg; 3/8 | ChEMBL. | 9406596 |
HSAI (binding) | = 75 | Human serum albumin index was measured by retention time of the compound on an HPLC column containing human albumin | ChEMBL. | 9406596 |
HSAI (binding) | = 75 | Human serum albumin index was measured by retention time of the compound on an HPLC column containing human albumin | ChEMBL. | 9406596 |
IC50 (binding) | = 42.7 nM | Affinity for the glycine binding site on rat N-methyl-D-aspartate glutamate receptor 1, determined by displacement of the glycine site antagonist [3H]L-689,560 from rat cortical membranes | ChEMBL. | 9406596 |
IC50 (binding) | = 42.7 nM | Affinity for the glycine binding site on rat N-methyl-D-aspartate glutamate receptor 1, determined by displacement of the glycine site antagonist [3H]L-689,560 from rat cortical membranes | ChEMBL. | 9406596 |
logP (ADMET) | = 3.31 | Partition coefficient (logP) | ChEMBL. | 9406596 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.